According to IMARC Group, the global erythropoietin drugs market size reached USD 12,097.4 Million in 2025 and is projected to reach USD 18,184.2 Million by 2034, expanding at a CAGR of 4.49% during 2026-2034. This steady growth trajectory reflects the rising global burden of chronic kidney disease and cancer, continuous innovation in biopharmaceutical research, and the accelerating shift...